{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:33:52Z","timestamp":1772692432758,"version":"3.50.1"},"reference-count":146,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"John & Mary Kibble Trust","award":["619915"],"award-info":[{"award-number":["619915"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Establishing plasma biomarkers in the veterinary field has always been a challenge, due to a lack of significant understanding of pathophysiological attributes of disease. Advances in mass spectrometry-based proteomic techniques have improved plasma biomarker discovery in veterinary medicine. Feline hypertrophic cardiomyopathy is the most common cardiac disease in cats and has a complex and not fully elucidated pathophysiology. This study aimed to use SWATH-MS proteomics to identify novel plasma biomarkers for fHCM and to further elucidate disease pathogenesis. Plasma was collected from 20 cats, consisting of healthy controls (n = 10) and a HCM group (n = 10). Cats with fHCM, were diagnosed by echocardiography and disease statuses were determined by a veterinary cardiologist. Undepleted cat plasma samples were digested using FASP and quantitative analysis was performed using DIA-NN. A total of 40 plasma proteins were found to be dysregulated, primarily associated with innate and humoral responses, including complement C7 and C9 and properdin proteins. Other dysregulated proteins were involved in blood coagulation (fibrinogen, fibulin-1), lipid metabolism (apolipoproteins), and inflammation pathways (transthyretin and plasminogen). These findings provide possible biomarkers for fHCM, with the potential to detect disease before clinical signs become evident, which is a significant outcome for fHCM. These proteomic changes suggest critical pathways for earlier intervention and could potentially lead to more effective treatment outcomes. Furthermore, having significant similarity to human disease strengthens the case for using cats as a potential translational model for hHCM.<\/jats:p>","DOI":"10.3390\/ani16050781","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:18:45Z","timestamp":1772554725000},"page":"781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Pathophysiological Complexity of Feline Hypertrophic Cardiomyopathy Using SWATH-MS Plasma Proteomics"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-4167","authenticated-orcid":false,"given":"Halley Gora","family":"Ravuri","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia"},{"name":"School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-2461","authenticated-orcid":false,"given":"Andrea L.","family":"Daniels","sequence":"additional","affiliation":[{"name":"School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-3490","authenticated-orcid":false,"given":"Pawel","family":"Sadowski","sequence":"additional","affiliation":[{"name":"Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD 4000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-9666","authenticated-orcid":false,"given":"Paul C.","family":"Mills","sequence":"additional","affiliation":[{"name":"School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2460\/javma.234.11.1398","article-title":"Prevalence of cardiomyopathy in apparently healthy cats","volume":"234","author":"Paige","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/j.jvc.2015.03.008","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/cr578w","article-title":"Feline hypertrophic cardiomyopathy: A spontaneous large animal model of human HCM","volume":"8","author":"Freeman","year":"2017","journal-title":"Cardiol. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1038\/s41598-023-36932-5","article-title":"Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C","volume":"13","author":"Stern","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1748-5827.2010.00989.x","article-title":"Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005)","volume":"51","author":"Payne","year":"2010","journal-title":"J. Small Anim. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1939-1676.2009.0341.x","article-title":"Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy","volume":"23","author":"Meurs","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1939-1676.2011.0751.x","article-title":"Prevalence of hypertrophic cardiomyopathy in a cohort of British Shorthair cats in Denmark","volume":"25","author":"Godiksen","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.jvc.2015.07.003","article-title":"Screening for hypertrophic cardiomyopathy in cats","volume":"17","author":"Wess","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jvc.2015.03.007","article-title":"Hypertrophic cardiomyopathy in man and cats","volume":"17","author":"Maron","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cvsm.2017.05.002","article-title":"Asymptomatic hypertrophic cardiomyopathy: Diagnosis and therapy","volume":"47","author":"Wilkie","year":"2017","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Messer, A.E., Chan, J., Daley, A., Copeland, O., Marston, S.B., and Connolly, D.J. (2017). Investigations into the sarcomeric protein and Ca2+-regulation abnormalities underlying hypertrophic cardiomyopathy in cats (Felis catus). Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00348"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jvim.16576","article-title":"Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study","volume":"36","author":"Payne","year":"2022","journal-title":"J. Vet. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","article-title":"Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"98","author":"Kuusisto","year":"2012","journal-title":"Heart"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10741-023-10307-4","article-title":"Inflammation across the spectrum of hypertrophic cardiac phenotypes","volume":"28","author":"Lillo","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11239-019-02026-1","article-title":"Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy","volume":"49","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Thomas, T.P., and Grisanti, L.A. (2020). The dynamic interplay between cardiac inflammation and fibrosis. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.529075"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41569-018-0077-x","article-title":"The interstitium in cardiac repair: Role of the immune\u2013stromal cell interplay","volume":"15","author":"Forte","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Monda, E., Palmiero, G., Rubino, M., Verrillo, F., Amodio, F., Di Fraia, F., Pacileo, R., Fimiani, F., Esposito, A., and Cirillo, A. (2020). Molecular basis of inflammation in the pathogenesis of cardiomyopathies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186462"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1354\/vp.42-4-458","article-title":"Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy","volume":"42","author":"Cesta","year":"2005","journal-title":"Vet. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tvjl.2014.11.018","article-title":"Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy","volume":"203","author":"Khor","year":"2015","journal-title":"Vet. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0300985819837717","article-title":"Feline hypertrophic cardiomyopathy: The consequence of cardiomyocyte-initiated and macrophage-driven remodeling processes?","volume":"56","author":"Kitz","year":"2019","journal-title":"Vet. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/03009858211062631","article-title":"Feline hypertrophic cardiomyopathy: Reduced microvascular density and involvement of CD34+ interstitial cells","volume":"59","author":"Fonfara","year":"2022","journal-title":"Vet. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/JLB.3MIR0220-270R","article-title":"Complement: Bridging the innate and adaptive immune systems in sterile inflammation","volume":"108","author":"Lo","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.33549\/physiolres.933253","article-title":"Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure","volume":"65","author":"Rehulkova","year":"2016","journal-title":"Physiol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s42485-019-00004-y","article-title":"Quantitative proteomics study reveals differential proteomic signature in dilated, restrictive, and hypertrophic cardiomyopathies","volume":"10","author":"Ghose","year":"2019","journal-title":"J. Proteins Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1074\/mcp.RA119.001586","article-title":"Identification of a multiplex biomarker panel for hypertrophic cardiomyopathy using quantitative proteomics and machine learning","volume":"19","author":"Captur","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e007849","DOI":"10.1161\/CIRCHEARTFAILURE.120.007849","article-title":"Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy","volume":"14","author":"Shimada","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103896","DOI":"10.1016\/j.jprot.2020.103896","article-title":"Novel biomarkers in cats with congestive heart failure due to primary cardiomyopathy","volume":"226","author":"Liu","year":"2020","journal-title":"J. Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rivas, V.N., Kaplan, J.L., Kennedy, S.A., Fitzgerald, S., Crofton, A.E., Farrell, A., Grubb, L., Jauregui, C.E., Grigorean, G., and Choi, E. (2023). Multi-omic, histopathologic, and clinicopathologic effects of once-weekly oral rapamycin in a naturally occurring feline model of hypertrophic cardiomyopathy: A pilot study. Animals, 13.","DOI":"10.3390\/ani13203184"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1136\/hrt.2007.126896","article-title":"Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation","volume":"94","author":"Dimitrow","year":"2008","journal-title":"Heart"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.hrthm.2018.11.029","article-title":"Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation","volume":"16","author":"Tsuda","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10840-023-01642-5","article-title":"Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"67","author":"Burczak","year":"2024","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1939-165X.2007.tb00203.x","article-title":"Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy","volume":"36","author":"Dunn","year":"2007","journal-title":"Vet. Clin. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jvim.12325","article-title":"Platelet activation in cats with hypertrophic cardiomyopathy","volume":"28","author":"Tablin","year":"2014","journal-title":"J. Vet. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cvsm.2023.06.002","article-title":"Preventing cardiogenic thromboembolism in cats: Literature gaps, rational recommendations, and future therapies","volume":"53","author":"Shaverdian","year":"2023","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1939-1676.2008.0098.x","article-title":"Hypercoagulability in cats with cardiomyopathy","volume":"22","author":"Stokol","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: Strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"152707","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk\u2014Factor H in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1136\/heartjnl-2021-320729","article-title":"Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy","volume":"108","author":"Liang","year":"2022","journal-title":"Heart"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ahj.2006.03.007","article-title":"Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma","volume":"152","author":"Donahue","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1039\/D1MO00354B","article-title":"Investigation of cattle plasma proteome in response to pain and inflammation using next generation proteomics technique, SWATH-MS","volume":"18","author":"Ghodasara","year":"2022","journal-title":"Mol. Omics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104384","DOI":"10.1016\/j.jprot.2021.104384","article-title":"Leveraging homologies for cross-species plasma proteomics in ungulates using data-independent acquisition","volume":"250","author":"Noor","year":"2022","journal-title":"J. Proteom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104648","DOI":"10.1016\/j.jprot.2022.104648","article-title":"Plasma proteomic changes in response to surgical trauma and a novel transdermal analgesic treatment in dogs","volume":"265","author":"Ravuri","year":"2022","journal-title":"J. Proteom."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.jproteome.3c00074","article-title":"Automated proteomics workflows for high-throughput library generation and biomarker detection using data-independent acquisition","volume":"22","author":"Paramasivan","year":"2023","journal-title":"J. Proteome Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ware, W.A. (2011). Cardiovascular Disease in Small Animal Medicine, CRC Press.","DOI":"10.1201\/b15177"},{"key":"ref_47","unstructured":"Kittleson, M.D., and Kienle, R.D. (1998). Small Animal Cardiovascular Medicine, Mosby."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Korobova, V., and Kruglova, Y. (2024). Influence of clinical aspects and genetic factors on feline HCM severity and development. Vet. Sci., 11.","DOI":"10.3390\/vetsci11050214"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Zougman","year":"2009","journal-title":"Nat. Methods"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth.2834","article-title":"Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells","volume":"11","author":"Kulak","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ravuri, H.G., Noor, Z., Mills, P.C., Satake, N., and Sadowski, P. (2022). Data-independent acquisition enables robust quantification of 400 proteins in non-depleted canine plasma. Proteomes, 10.","DOI":"10.3390\/proteomes10010009"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: Neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/gkn760","article-title":"STRING 8\u2014A global view on proteins and their functional interactions in 630 organisms","volume":"37","author":"Jensen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0195-5616(96)50058-6","article-title":"Antithrombotic and fibrinolytic factors","volume":"26","author":"Welles","year":"1996","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/acsomega.8b02207","article-title":"Glycoproteomic profiling provides candidate myocardial infarction predictors of later progression to heart failure","volume":"4","author":"Ero","year":"2019","journal-title":"ACS Omega"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1556-4029.2012.02172.x","article-title":"Recognition of early myocardial infarction by immunohistochemical staining with cardiac troponin-I and complement C9","volume":"57","author":"Jasra","year":"2012","journal-title":"J. Forensic Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41467-023-44680-3","article-title":"Large-scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development","volume":"15","author":"Shah","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1038\/s41467-019-13306-y","article-title":"Profiling of the plasma proteome across different stages of human heart failure","volume":"10","author":"Egerstedt","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jtha.2024.04.026","article-title":"Plasma levels of complement components C5 and C9 are associated with thrombin generation","volume":"22","author":"Munsch","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc11-1483","article-title":"Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes","volume":"35","author":"Somani","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00467-018-4042-z","article-title":"The role of properdin in complement-mediated renal diseases: A new player in complement-inhibiting therapy?","volume":"34","author":"Michels","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2018.05.018","article-title":"Properdin: A multifaceted molecule involved in inflammation and diseases","volume":"102","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/imr.12466","article-title":"Properdin: A tightly regulated critical inflammatory modulator","volume":"274","author":"Blatt","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0161-5890(02)00215-8","article-title":"The endothelium as a physiological source of properdin: Role of wall shear stress","volume":"39","author":"Bongrazio","year":"2003","journal-title":"Mol. Immunol."},{"key":"ref_67","first-page":"446","article-title":"The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes: The CODAM study","volume":"111","author":"Hertle","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/heartjnl-2012-301730","article-title":"Does inflammation trigger fibrosis in hypertrophic cardiomyopathy: A burning question?","volume":"98","author":"Westermann","year":"2012","journal-title":"Heart"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/cvr\/cvae086","article-title":"Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: A large-scale computational study","volume":"120","author":"Coleman","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.175.1.541","article-title":"Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury","volume":"175","author":"Walsh","year":"2005","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1586\/eri.11.136","article-title":"Mannose-binding lectin and the balance between immune protection and complication","volume":"9","author":"Takahashi","year":"2011","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/pr.111.005223","article-title":"International Union of Basic and Clinical Pharmacology: C3a and C5a Receptors","volume":"65","author":"Klos","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e004448","DOI":"10.1161\/CIRCGEN.123.004448","article-title":"Novel multiplexed plasma biomarker panel has diagnostic and prognostic potential in children with hypertrophic cardiomyopathy","volume":"17","author":"Captur","year":"2024","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.cardfail.2020.09.063","article-title":"C3a, C4a, and C5a complement anaphylatoxins are paradoxically decreased in acute and chronic heart failure","volume":"26","author":"Morales","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00392-012-0432-6","article-title":"Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure","volume":"101","author":"Gombos","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvim.15122","article-title":"International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL study","volume":"32","author":"Fox","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and fibrin in hemostasis and thrombosis","volume":"37","author":"Kattula","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: Both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/qjmed\/hcg129","article-title":"Fibrinogen: Biochemistry, epidemiology and determinants","volume":"96","author":"Kamath","year":"2003","journal-title":"QJM Int. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2141.1972.tb08791.x","article-title":"Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products","volume":"22","author":"Ekert","year":"1972","journal-title":"Br. J. Haematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1334483","article-title":"Plasminogen receptors: The first quarter century","volume":"39","author":"Miles","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e20191865","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen is a complement inhibitor","volume":"287","author":"Barthel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(16)30365-6","article-title":"Examining coagulation-complement crosstalk: Complement activation and thrombosis","volume":"141","author":"Foley","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.13150","article-title":"The complement alternative pathway and hemostasis","volume":"313","author":"Noris","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1432-1033.1987.tb13551.x","article-title":"Amino acid sequence of human \u03b12-antiplasmin","volume":"166","author":"Lijnen","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: From structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_89","unstructured":"And\u014d, H., Ukena, K., and Nagata, S. (2021). Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research, Elsevier. [2nd ed.]."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.biochi.2010.03.011","article-title":"Kininogens: More than cysteine protease inhibitors and kinin precursors","volume":"92","author":"Lalmanach","year":"2010","journal-title":"Biochimie"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"109761","DOI":"10.1016\/j.cellsig.2020.109761","article-title":"The multifaceted role of plasminogen in inflammation","volume":"75","author":"Heissig","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jvim.16676","article-title":"Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism","volume":"37","author":"Li","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"19458","DOI":"10.1074\/jbc.270.33.19458","article-title":"The interaction of fibulin-1 with fibrinogen: A potential role in hemostasis and thrombosis","volume":"270","author":"Tran","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00418-009-0628-7","article-title":"Fibulin-1 and fibrinogen in human atherosclerotic lesions","volume":"132","author":"Argraves","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1073\/pnas.97.9.4826","article-title":"Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy","volume":"97","author":"Redfern","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2012.01.045","article-title":"NT-proBNP is associated with fibulin-1 in Africans: The SAfrEIC study","volume":"222","author":"Kruger","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2840-12-6","article-title":"Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes","volume":"12","author":"Scholze","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12079-009-0065-3","article-title":"Fibulin-5, an integrin-binding matricellular protein: Its function in development and disease","volume":"3","author":"Yanagisawa","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Nijenkamp, L.L.A.M., Bollen, I.A.E., Niessen, H.W.M., dos Remedios, C.G., Michels, M., Poggesi, C., Ho, C.Y., Kuster, D.W.D., and van der Velden, J. (2020). Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0232427"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijcard.2007.04.003","article-title":"Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis","volume":"126","author":"Johansson","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(20)32011-0","article-title":"Circulating ACE2: A novel biomarker of cardiovascular risk","volume":"396","author":"Ramchand","year":"2020","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin\u2013angiotensin\u2013aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/HYPERTENSIONAHA.120.15829","article-title":"Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure","volume":"76","author":"Chirinos","year":"2020","journal-title":"Hypertension"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvim.16401","article-title":"Circulating renin\u2013angiotensin\u2013aldosterone system activity in cats with systemic hypertension or cardiomyopathy","volume":"36","author":"Ward","year":"2022","journal-title":"J. Vet. Intern. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jvim.15948","article-title":"Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease","volume":"35","author":"Huh","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jchf.2022.06.005","article-title":"Angiotensinogen","volume":"10","author":"Kahlon","year":"2022","journal-title":"JACC Heart Fail."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Manolis, A.A., Manolis, T.A., and Manolis, A.S. (2023). Neurohumoral activation in heart failure. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015472"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jclinpath-2020-206954","article-title":"Molecules in pathogenesis: Angiotensin-converting enzyme 2 (ACE2)","volume":"74","author":"Wiese","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Luo, D., Bai, M., Zhang, W., and Wang, J. (2024). The possible mechanism and research progress of ACE2 involved in cardiovascular injury caused by COVID-19: A review. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1409723"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/ndt\/gft240","article-title":"Reduced plasma ACE2 activity in dialysis patients: Another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?","volume":"28","author":"Wysocki","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.rvsc.2022.09.024","article-title":"Elevated angiotensin-converting enzyme 2 (ACE2) expression in cats with hypertrophic cardiomyopathy","volume":"152","author":"Lean","year":"2022","journal-title":"Res. Vet. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: A case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Sorg","year":"2010","journal-title":"Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/1098612X13516478","article-title":"Comparison of serum fatty acid concentrations in cats with hypertrophic cardiomyopathy and healthy controls","volume":"16","author":"Hall","year":"2014","journal-title":"J. Feline Med. Surg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2015.03.038","article-title":"Apolipoprotein M","volume":"446","author":"Ren","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00125-019-4847-8","article-title":"Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: The Multi-Ethnic Study of Atherosclerosis","volume":"62","author":"Aroner","year":"2019","journal-title":"Diabetologia"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"154395","DOI":"10.1016\/j.metabol.2020.154395","article-title":"ApoCIII: A multifaceted protein in cardiometabolic disease","volume":"113","author":"Gallo","year":"2020","journal-title":"Metabolism"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4155\/tde-2017-0073","article-title":"The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer","volume":"9","author":"Pak","year":"2018","journal-title":"Ther. Deliv."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin\u2013retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10577-010-9180-5","article-title":"The Ndc80 complex: Integrating the kinetochore\u2019s many movements","volume":"19","author":"Tooley","year":"2011","journal-title":"Chromosome Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1098-612X(02)00133-X","article-title":"Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994\u20132001)","volume":"5","author":"Ferasin","year":"2003","journal-title":"J. Feline Med. Surg."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Joshua, J., Caswell, J., O\u2019Sullivan, M.L., Wood, G., and Fonfara, S. (2023). Feline myocardial transcriptome in health and in hypertrophic cardiomyopathy: A translational animal model for human disease. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0283244"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e003756","DOI":"10.1161\/CIRCGEN.122.003756","article-title":"Multi-omic architecture of obstructive hypertrophic cardiomyopathy","volume":"16","author":"Garmany","year":"2023","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Laird, J., Perera, G., Batorsky, R., Wang, H., Arkun, K., and Chin, M.T. (2023). Spatial transcriptomic analysis of focal and normal areas of myocyte disarray in human hypertrophic cardiomyopathy. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202307.0139.v1"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3000605231213781","DOI":"10.1177\/03000605231213781","article-title":"Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning","volume":"51","author":"You","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Zhang, X.Z., Zhang, S., Tang, T.T., and Cheng, X. (2021). Bioinformatics and immune infiltration analyses reveal the key pathway and immune cells in the pathogenesis of hypertrophic cardiomyopathy. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.696321"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Zheng, X., Liu, G., and Huang, R. (2021). Identification and verification of feature immune-related genes in patients with hypertrophic cardiomyopathy based on bioinformatics analyses. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.752559"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exger.2015.09.018","article-title":"Age- and gender-dependent myocardial transcription patterns of cytokines and extracellular matrix remodelling enzymes in cats with non-cardiac diseases","volume":"72","author":"Fonfara","year":"2015","journal-title":"Exp. Gerontol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rvsc.2022.07.007","article-title":"Cardiac gene activation varies between young and adult cats and in the presence of hypertrophic cardiomyopathy","volume":"152","author":"Colpitts","year":"2022","journal-title":"Res. Vet. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11886-023-01876-9","article-title":"Mechanisms of sarcomere protein mutation-induced cardiomyopathies","volume":"25","author":"Barefield","year":"2013","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12014-024-09497-2","article-title":"Frontiers in plasma proteome profiling platforms: Innovations and applications","volume":"21","author":"Soni","year":"2024","journal-title":"Clin. Proteom."},{"key":"ref_134","first-page":"100827","article-title":"Mitochondrial metabolic remodeling and multi-omics profiling identify plasma biomarkers of myocardial infarction","volume":"14","author":"Paramasivan","year":"2025","journal-title":"J. Mol. Cell. Cardiol. Plus"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1016\/j.cell.2025.03.013","article-title":"Human proteome distribution atlas for tissue-specific plasma proteome dynamics","volume":"188","author":"Hauri","year":"2025","journal-title":"Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00395-013-0375-8","article-title":"Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth","volume":"108","author":"Konstandin","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yjmcc.2015.12.009","article-title":"Thrombospondins in the transition from myocardial infarction to heart failure","volume":"90","author":"Kirk","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2019.12.011","article-title":"Cathelicidin aggravates myocardial ischemia\/reperfusion injury via activating TLR4 signaling and P2X7R\/NLRP3 inflammasome","volume":"139","author":"Wu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Duan, Y., Tang, H., Mitchell-Silbaugh, K., Fang, X., Han, Z., and Ouyang, K. (2020). Heat shock protein 60 in cardiovascular physiology and diseases. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00073"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"9747","DOI":"10.2147\/IJGM.S345921","article-title":"Integrative bioinformatics analysis revealed mitochondrial defects underlying hypoplastic left heart syndrome","volume":"14","author":"Zhao","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.vetimm.2010.10.003","article-title":"Utility, limitations, and promise of proteomics in animal science","volume":"138","author":"Lippolis","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tvjl.2017.10.022","article-title":"Clinical veterinary proteomics: Techniques and approaches to decipher the animal plasma proteome","volume":"230","author":"Ghodasara","year":"2017","journal-title":"Vet. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/vco.12826","article-title":"Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry","volume":"20","author":"Nabeta","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidence","volume":"50","author":"Bai","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: An R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: Integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:11:11Z","timestamp":1772687471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":146,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ani16050781"],"URL":"https:\/\/doi.org\/10.3390\/ani16050781","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}